德国默克集团最近宣布将在中国江苏南通经济技术开发区投资6.5亿人民币建设其在中国的第一家制药工厂,该工厂也将同时成为默克全球的第二大制药工厂。默克雪兰诺总裁兼首席执行官葛丽鹤透露,该工厂将主要生产默克在中国国家基本药物目录中的品牌产品,包括糖尿病、心血管疾病、甲状腺功能失调等多种疾病领域——作 Merck KGaA recently announced that it will invest 650 million renminbi to build its first pharmaceutical factory in China in Nantong Economic and Technological Development Zone in Jiangsu Province, China. The plant will also become Merck’s second largest pharmaceutical factory in the world. Ge Lihe, president and chief executive officer of Merck Serono, said the plant will mainly produce Merck’s branded products in China’s national essential medicines list, including diabetes, cardiovascular disease, thyroid dysfunction and other diseases -